Back to search

Article

A non-canonical glucose metabolic rewiring enables resistance to cancer targeted therapy

2024-12-20

Abstract excerpt

Targeting glucose metabolism for cancer therapy is a long-lasting pursuit but with disappointing translational success. Revelation of actionable distinctions between the malignancy traits to achieve selectivity is a prerequisite for fulfilling a therapeutic window. We discover a non-canonical glucose transporter GLUT6-facilitated, lactate-independent, glucose metabolic rewiring that selectively enables resistance...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e0ff8d6d-6abb-53b5-8b36-233147d4f1ae
DOI
10.1101/2024.12.19.629335
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A non-canonical glucose metabolic rewiring enables resistance to cancer targeted therapyDOI 10.1101/2024.12.19.629335
Select a neighboring publication to make it the new centre.